Navigation Links
VIDA Diagnostics Gains FDA Approval for Comprehensive Lung Analysis Software
Date:11/28/2008

IOWA CITY, Iowa, Nov. 28 /PRNewswire/ -- VIDA Diagnostics Inc. announced today that its primary product, Pulmonary Workstation 2.0 (PW2) has obtained FDA 510(k) clearance for sale.

PW2 is the first commercial release of lung image analysis software from VIDA and comprises a comprehensive approach to quantitative, repeatable lung measurements including the industry's first so-approved automatic lobe density and airway system measurement functions.

"We are privileged to be given the opportunity to make our leading PW2 application available to assist in the evaluation of millions of chronic obstructive pulmonary disease (COPD) and emphysema patients throughout the U.S.," said John Garber, VIDA CEO. "Since these diseases often affect specific regions of the lung, the ability to individually and objectively measure each of the five lobes and 25 major airways should fast become an invaluable complement to existing systemic measures like pulmonary function tests."

VIDA's PW2 takes the complex information from a CT (computed tomography) scan of the lung and converts it into useful 3D images and measurements that are easily viewed by the practicing pulmonologist at the point of patient service, or by the radiologist in the radiology department. PW2 features include a number of lung or lobe volume and density measurements, an extensive named airway map and a full suite of measurement tools for each airway. For the first time, airway, lung, and lobe measurement tools are combined with advanced airway visualization to aid in patient assessment and procedure planning.

"With installations at 27 top research sites processing over 10,000 CT scans in the last three years, PW2 has proven to be a very reliable software package," said Juerg Tschirren, VIDA Vice President of Engineering. "After extensive validation and testing, we are pleased to release our software, Pulmonary Workstation 2.0, for clinical use."


'/>"/>
SOURCE VIDA Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Quest Diagnostics to Speak at the 2008 Credit Suisse Healthcare Conference
2. Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008
3. InHealth awards grants to study impact of medical diagnostics and devices on patients, health care
4. Quest Diagnostics to Release Third Quarter 2008 Financial Results
5. ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
6. Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria
7. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
8. Caris Diagnostics Providing KRAS Mutational Analysis for Colon Cancer Patients
9. Quest Diagnostics to Speak at the Jefferies 2nd Annual Healthcare Conference
10. Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland through Irelands First Nationwide Cervical-Cancer Screening Program
11. Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... on foundational and sustainable systems change designed to further positively impact the health ... Board of Trustees has long considered it our duty to seriously consider releasing ...
(Date:2/17/2017)... VA (PRWEB) , ... February ... ... FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. 22, 2017 ... What are the critical reimbursement questions manufacturers should be asking before selecting ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one ... in the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare ... is recognized across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... ... February 17, 2017 , ... MAP Revenue ... that Karen Pilley has been promoted to Chief Executive Officer. , The ... paradigm – a shift that demands the transition from pay-for-service to pay-for-performance models. ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... sponsor and exhibitor at Molecular Medicine Tri-Conference February 20 – 22 in San ... Inspirata will showcase its anatomic and molecular pathology workflow solution, as well as ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... YORK , Feb. 17, 2017  BioDigital, ... today the partnership of their 3D body mapping ... healthcare IT.  The new integration will be used ... an interactive model of the human body. BioDigital ... saves clinicians time, while also increasing the precision ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... 16, 2017  Newly published research from the CVS ... the role a private retailer can play in restricting ... published online today in the American Journal of ... remove tobacco from all CVS Pharmacy stores reduced the ... an even greater impact on those who bought cigarettes ...
Breaking Medicine Technology: